Comparison
2p21 Microdeletion Syndrome Without Cystinuria C4749458 vs 13q12 3 Microdeletion Syndrome C4750951
Clinical comparison between 2p21 Microdeletion Syndrome Without Cystinuria and 13q12 3 Microdeletion Syndrome for differential diagnosis and treatment planning.
2p21 Microdeletion Syndrome Without Cystinuria C4749458
A chromosomal deletion on chromosome 2 involving some genes shared with another condition but without the kidney component. Supportive care addresses each person's specific needs.
13q12 3 Microdeletion Syndrome C4750951
A rare genetic condition where a small piece of chromosome 13 is missing. It can cause various developmental and medical concerns. Care is supportive and tailored to the individual's needs.
6 comparison axes
Onset
2p21 Microdeletion Syndrome Without Cystinuria C4749458
0-null
13q12 3 Microdeletion Syndrome C4750951
0-null
Onset patterns differ
Severity
2p21 Microdeletion Syndrome Without Cystinuria C4749458
severe
13q12 3 Microdeletion Syndrome C4750951
moderate
Different severity levels
Chronic
2p21 Microdeletion Syndrome Without Cystinuria C4749458
Chronic
13q12 3 Microdeletion Syndrome C4750951
Chronic
Differing course
Communicable
2p21 Microdeletion Syndrome Without Cystinuria C4749458
No
13q12 3 Microdeletion Syndrome C4750951
No
Different transmission
Body System
2p21 Microdeletion Syndrome Without Cystinuria C4749458
congenital
13q12 3 Microdeletion Syndrome C4750951
congenital
Same/different system
Category
2p21 Microdeletion Syndrome Without Cystinuria C4749458
rare-disease
13q12 3 Microdeletion Syndrome C4750951
genetic
Different category
Bottom line
2p21-microdeletion-syndrome-without-cystinuria-C4749458 and 13q12-3-microdeletion-syndrome-C4750951 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 2p21 Microdeletion Syndrome Without Cystinuria C4749458 | 13q12 3 Microdeletion Syndrome C4750951 | Discriminating power |
|---|---|---|---|
| Chromosomal locus | Deletion involving 2p21 and defined without cystinuria. | Small deletion involving 13q12.3. | High |
| Cystinuria or kidney feature | Cystinuria is excluded by the concept name; other kidney findings are not established. | No cystinuria association is established in the supplied data. | Moderate |
| Severity classification | Source label is severe, not an individual prognosis. | Source label is moderate, not an individual prognosis. | Low |
When to favor each condition
Choose 2p21 Microdeletion Syndrome Without Cystinuria C4749458 when
A genetic report confirms a 2p21 deletion and cystinuria is absent.
This matches the named left concept rather than a 13q deletion.
High
The imbalance is localized to chromosome 2p21.
The chromosomal locus is the main established discriminator.
High
Only the source severity classification is being compared.
The left concept is labeled severe, but personal outcome is not established.
Low
Choose 13q12 3 Microdeletion Syndrome C4750951 when
A genetic report confirms a 13q12.3 microdeletion.
The locus identifies the right concept.
High
Developmental concerns occur with a result pointing to 13q12.3 rather than 2p21.
The supplied description allows varied concerns but requires genetic localization.
Moderate
A moderate source severity label is the only available comparison.
This is a classification, not proof of a milder course for an individual.
Low
How key tests differ
| Test | 2p21 Microdeletion Syndrome Without Cystinuria C4749458 | 13q12 3 Microdeletion Syndrome C4750951 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | Deletion signal at 2p21. | Deletion signal at 13q12.3. | Locus distinguishes them; deletion size and genes require the laboratory report. |
| Karyotype | A small 2p21 deletion may not be visible. | A small 13q12.3 deletion may not be visible. | A normal karyotype excludes neither; a higher-resolution test is more informative. |
| Urine cystine or kidney evaluation | Cystinuria is not part of this named entity. | No specific cystine pattern is established. | Urine testing alone cannot choose between these concepts. |
Prognosis comparison
2p21 Microdeletion Syndrome Without Cystinuria C4749458
- Outcome
- Long-term outcome is not established; the source severity label is severe.
- Factors
- Deletion content, associated findings, and available supports are relevant but unquantified.
13q12 3 Microdeletion Syndrome C4750951
- Outcome
- Long-term outcome is not established; the source severity label is moderate.
- Factors
- Individual developmental and medical findings are relevant but unspecified.
Time frame: Both are described as chronic; onset data are incomplete.
The genetic report and clinical evaluation matter more than severity labels.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental or medical needs | Possible, but the specific pattern is not established. Various developmental and medical concerns are possible but unspecified. Needs should be assessed individually. |
| Kidney or cystine complication | Cystinuria is excluded by name, while other kidney issues are not ruled out. No kidney complication is established from the supplied data. Do not infer kidney risk from the comparison alone. |
| Lifelong supportive-care needs | Chronic congenital condition managed supportively. Chronic congenital condition with tailored supportive care. Neither description predicts particular complications. |
Patient education highlights
- HighGenetic confirmation
The laboratory locus, not symptoms alone, distinguishes these concepts.
- HighSupportive care
Care is individualized; no treatment dose or standard regimen is established here.
- MediumGenetics counseling
Inheritance and family testing are not specified and should be discussed with a genetics clinician.